The Technology Innovation Momentum Fund (Momentum Fund) is the most recent of Ramot's funds to become operational.
The Momentum Fund, with an oversubscribed level of investment of $23.5 million, invests in promising breakthrough technologies in a wide range of fields, including pharmaceuticals, healthcare, high-tech and the physical sciences.
The Fund's lead investor is the Tata Group, Ltd. and another key investor is Temasek, a Singapore-based investment company. Momentum Fund investment recipients are early stage innovative projects that can receive $250,000 to $1,000,000 to further their research with an eye to rapid commercialization of the developments. Toward this end, TAU researchers involved in the funded projects receive the Fund's and Ramot's assistance in creating connections with industry and guidance in all aspects involved in transforming projects into products.

The Momentum Fund, with an oversubscribed level of investment of $23.5 million, invests in promising breakthrough technologies in a wide range of fields, including pharmaceuticals, healthcare, high-tech and the physical sciences.

More detailed information about the Fund and its investments on this site is available to current investors only via login. This includes profiles, details and progress reports for the funded projects, financial reports, and information about the committee members, upcoming meetings dates and protocols from previous meetings.To learn more about investment opportunities in The Momentum Fund, contact Ramot@ramot.org. ​
 

Image CAPTCHA